Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 194

1.

Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study.

Roshanov PS, Eikelboom JW, Crowther M, Tandon V, Borges FK, Kearon C, Lamy A, Whitlock R, Biccard BM, Szczeklik W, Guyatt GH, Panju M, Spence J, Garg AX, McGillion M, VanHelder T, Kavsak PA, de Beer J, Winemaker M, Sessler DI, Le Manach Y, Sheth T, Pinthus JH, Thabane L, Simunovic MRI, Mizera R, Ribas S, Devereaux PJ; Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Investigators.

CMAJ Open. 2017 Aug 4;5(3):E594-E603. doi: 10.9778/cmajo.20160106.

2.

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, B├╝ller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA; MARVELOUS Collaborators.

BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950.

3.

Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism.

Takach Lapner S, Julian JA, Linkins LA, Bates S, Kearon C.

Thromb Haemost. 2017 Oct 5;117(10):1937-1943. doi: 10.1160/TH17-03-0182. Epub 2017 Aug 3.

PMID:
28771280
4.

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ; REVERSE II Study Investigators.

BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.

5.

Managing challenging patients with venous thromboembolism: a practical, case-based approach.

Douketis J, Ageno W, Carrier M, Kearon C.

Pol Arch Intern Med. 2017 Jan 4;127(1):41-46. doi: 10.20452/pamw.3879. Epub 2017 Jan 4. Review.

6.

Diagnosis of suspected venous thromboembolism.

Kearon C.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):397-403. Review.

PMID:
27913507
7.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies.

Takach Lapner S, Julian JA, Linkins LA, Bates SM, Kearon C.

J Thromb Haemost. 2016 Oct;14(10):1953-1959. doi: 10.1111/jth.13424. Epub 2016 Aug 31.

PMID:
27455175
8.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply.

Takach Lapner S, Julian JA, Linkins LA, Bates S, Kearon C.

J Thromb Haemost. 2016 Dec;14(12):2555-2556. doi: 10.1111/jth.13512. Epub 2016 Oct 20. No abstract available.

PMID:
27661781
9.

Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials.

Eikelboom JW, Kearon C, Guyatt G, Sessler DI, Yusuf S, Cook D, Douketis J, Patel A, Kurz A, Allard R, Jones PM, Dennis RJ, Painter TW, Bergese SD, Leslie K, Wijeysundera DN, Balasubramanian K, Duceppe E, Miller S, Diedericks J, Devereaux PJ.

Anesthesiology. 2016 Dec;125(6):1121-1129.

PMID:
27627817
10.

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.

Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease.

J Thromb Haemost. 2016 Jul;14(7):1480-3. doi: 10.1111/jth.13336. Epub 2016 Jun 7. No abstract available.

PMID:
27428935
11.

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Liaw PC, Weitz JI, Julian JA.

Thromb Res. 2016 Oct;146:119-125. doi: 10.1016/j.thromres.2016.06.023. Epub 2016 Jun 23.

PMID:
27354153
12.

Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel.

Sista AK, Goldhaber SZ, Vedantham S, Kline JA, Kuo WT, Kahn SR, Kabrhel C, McLaughlin VV, White SB, Kim NH, Gray M, Simon MA, Benenati JF, Misra S, Sterling KM, Kee ST, Konstantinides SV, Jaff MR, Kearon C.

J Vasc Interv Radiol. 2016 Jun;27(6):787-94. doi: 10.1016/j.jvir.2016.03.035. Epub 2016 Jun 3. No abstract available.

PMID:
27287967
13.

Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.

Vedantham S, Kahn SR, Goldhaber SZ, Comerota AJ, Parpia S, Meleth S, Earp D, Williams R, Sista AK, Marston W, Rathbun S, Magnuson EA, Razavi MK, Jaff MR, Kearon C.

Vasc Med. 2016 Aug;21(4):400-7. doi: 10.1177/1358863X16650747. Epub 2016 May 30.

14.

Inter-observer reliability of the HERDOO2 clinical decision rule.

Gauthier K, Le Gal G, Shivakumar S, Anderson D, Chagnon I, Solymoss S, Ortel T, Yeo E, Kearon C, Rodger M.

Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15. No abstract available.

PMID:
27031923
15.

Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis.

Rabinovich A, Cohen JM, Cushman M, Kahn SR; BioSOX Investigators.

J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):347-53.e1. doi: 10.1016/j.jvsv.2015.04.005. Epub 2015 Aug 1.

PMID:
26992609
16.

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L.

Chest. 2016 Feb;149(2):315-52. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.

PMID:
26867832
17.

Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.

Bates SM, Takach Lapner S, Douketis JD, Kearon C, Julian J, Parpia S, Schulman S, Weitz JI, Linkins LA, Crowther M, Lim W, Spencer FA, Lee AY, Gross PL, Ginsberg J.

J Thromb Haemost. 2016 Mar;14(3):504-9. doi: 10.1111/jth.13234. Epub 2016 Feb 5.

PMID:
26707364
18.

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism.

Majeed A, Goldhaber SZ, Kakkar A, Kearon C, Eriksson H, Kreuzer J, Feuring M, Hantel S, Friedman J, Schellong S, Schulman S.

Thromb Haemost. 2016 Jan;115(2):291-8. doi: 10.1160/TH15-04-0319. Epub 2015 Sep 24.

PMID:
26403199
19.

Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand?

Sista AK, Kearon C.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):1393-5. doi: 10.1016/j.jcin.2015.06.009. No abstract available.

20.

D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.

Kearon C, Stevens SM, Julian JA.

Ann Intern Med. 2015 May 5;162(9):671. doi: 10.7326/L15-5089-2. No abstract available.

PMID:
25939006

Supplemental Content

Loading ...
Support Center